Chinese dairy firm Yili 'weighing approach for infant-formula maker Ausnutria'
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Chinese dairy firm Yili said to be weighing approach for infant-formula maker Ausnutria

By Andy Coyne 04 Oct 2021 (Last Updated October 4th, 2021 17:40)

A media report said Yili has been speaking with banks about financing a possible acquisition.

Inner Mongolia Yili Industrial Group Co., China’s biggest dairy producer, has been linked with making a move for infant-formula firm Ausnutria.

According to news agency Bloomberg, citing people familiar with the matter, Yili, as it is more commonly known, has been speaking with banks about financing a possible acquisition of Hong Kong-listed Ausnutria.

However, the news agency’s sources qualified their comments by stressing deliberations are on-going and there is no certainty they will lead to a formal bid.

Ausnutria, which has its main headquarters in the Netherlands, counts Chinese state-backed investment firm Citic as its largest investor at present. It sells products in China, North America, the Middle East and parts of Europe, according to its website.

Its products include infant-formula based on goat milk and organic cows’ milk made under the Kabrita and Neolac brand names.

Bloomberg said Ausnutria has a market value of about US$1.8bn.

Just Food has asked both Yili and Ausnutria for a response to the story.

In May, Yili was linked with a bid for Reckitt Benckiser’s infant-formula business in China.